Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size ($ in 1000's) |
---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICS | 8,494,151 | +352,051 | $512,962 |
MLTX | 8,494,151 | +352,051 | $512,962 |
AMBRX BIOPHARMA INC | 11,231,000 | +1,307,311 | $159,929 |
AMAM | 11,231,000 | +1,307,311 | $159,929 |
EYEPOINT PHARMACEUTICALS INC | 6,038,235 | +2,838,235 | $139,544 |
EYPT | 6,038,235 | +2,838,235 | $139,544 |
BRIDGEBIO PHARMA INC | 3,344,179 | -1,318,351 | $135,005 |
BBIO | 3,344,179 | -1,318,351 | $135,005 |
ARCELLX INC | 1,700,000 | -450,000 | $94,350 |
ACLX | 1,700,000 | -450,000 | $94,350 |
RAYZEBIO INC | 1,213,478 | +31,215 | $75,442 |
RYZB | 1,213,478 | +31,215 | $75,442 |
BIOMEA FUSION INC | 3,570,872 | UNCH | $51,849 |
BMEA | 3,570,872 | UNCH | $51,849 |
IMMUNOVANT INC | 1,165,000 | -60,000 | $49,081 |
IMVT | 1,165,000 | -60,000 | $49,081 |
ALPINE IMMUNE SCIENCES INC | 2,550,000 | +650,000 | $48,603 |
ALPN | 2,550,000 | +650,000 | $48,603 |
PHARVARIS N V | 1,711,460 | +350,000 | $48,006 |
PHVS | 1,711,460 | +350,000 | $48,006 |
ALX ONCOLOGY HLDGS INC | 3,142,079 | +2,530,000 | $46,786 |
ALXO | 3,142,079 | +2,530,000 | $46,786 |
TARSUS PHARMACEUTICALS INC | 2,221,422 | -400,000 | $44,984 |
TARS | 2,221,422 | -400,000 | $44,984 |
CYMABAY THERAPEUTICS INC | 1,800,000 | -2,050,000 | $42,516 |
CBAY | 1,800,000 | -2,050,000 | $42,516 |
VAXCYTE INC | 665,000 | UNCH | $41,762 |
PCVX | 665,000 | UNCH | $41,762 |
CRINETICS PHARMACEUTICALS IN | 1,150,000 | +48,096 | $40,917 |
CRNX | 1,150,000 | +48,096 | $40,917 |
APELLIS PHARMACEUTICALS INC | 625,000 | -1,375,000 | $37,412 |
APLS | 625,000 | -1,375,000 | $37,412 |
MARINUS PHARMACEUTICALS INC | 3,250,000 | +625,000 | $35,328 |
MRNS | 3,250,000 | +625,000 | $35,328 |
AUTOLUS THERAPEUTICS PLC | 5,450,000 | +5,057,833 | $35,098 |
AUTL | 5,450,000 | +5,057,833 | $35,098 |
OLEMA PHARMACEUTICALS INC | 2,456,800 | -2,047,964 | $34,469 |
OLMA | 2,456,800 | -2,047,964 | $34,469 |
IMMUNEERING CORP | 4,204,364 | UNCH | $30,902 |
IMRX | 4,204,364 | UNCH | $30,902 |
EDGEWISE THERAPEUTICS INC | 2,551,989 | -394,898 | $27,919 |
EWTX | 2,551,989 | -394,898 | $27,919 |
AEROVATE THERAPEUTICS INC | 1,211,696 | -350,000 | $27,421 |
AVTE | 1,211,696 | -350,000 | $27,421 |
CARGO THERAPEUTICS INC | 1,182,563 | +1,182,563 | $27,376 |
CRGX | 1,182,563 | +1,182,563 | $27,376 |
HARPOON THERAPEUTICS INC | 2,349,060 | +2,295,000 | $26,709 |
HARP | 2,349,060 | +2,295,000 | $26,709 |
SYNDAX PHARMACEUTICALS INC | 1,175,000 | +1,175,000 | $25,392 |
SNDX | 1,175,000 | +1,175,000 | $25,392 |
KORRO BIO INC | 529,170 | +529,170 | $25,363 |
KRRO | 529,170 | +529,170 | $25,363 |
RHYTHM PHARMACEUTICALS INC | 550,000 | -300,000 | $25,284 |
RYTM | 550,000 | -300,000 | $25,284 |
ABIVAX SA | 2,130,000 | +2,130,000 | $22,791 |
ABVX | 2,130,000 | +2,130,000 | $22,791 |
INSMED INC | 575,000 | UNCH | $17,819 |
INSM | 575,000 | UNCH | $17,819 |
IDEAYA BIOSCIENCES INC | 450,000 | -150,000 | $16,011 |
IDYA | 450,000 | -150,000 | $16,011 |
AXONICS INC | 250,000 | UNCH | $15,558 |
AXNX | 250,000 | UNCH | $15,558 |
NEUROGENE INC | 746,180 | +746,180 | $14,461 |
NGNE | 746,180 | +746,180 | $14,461 |
LONGBOARD PHARMACEUTICALS IN | 2,353,141 | UNCH | $14,189 |
LBPH | 2,353,141 | UNCH | $14,189 |
PRAXIS PRECISION MEDICINES I | 633,345 | -8,866,655 | $14,111 |
PRAX | 633,345 | -8,866,655 | $14,111 |
ROCKET PHARMACEUTICALS INC | 450,000 | UNCH | $13,486 |
RCKT | 450,000 | UNCH | $13,486 |
RAPT THERAPEUTICS INC | 496,750 | +171,750 | $12,344 |
RAPT | 496,750 | +171,750 | $12,344 |
SPYRE THERAPEUTICS INC | 937,080 | +937,080 | $11,254 |
AGLE | 937,080 | +937,080 | $11,254 |
DISC MEDICINE INC | 125,000 | -100,000 | $7,220 |
IRON | 125,000 | -100,000 | $7,220 |
STOKE THERAPEUTICS INC | 1,087,807 | UNCH | $5,722 |
STOK | 1,087,807 | UNCH | $5,722 |
VERVE THERAPEUTICS INC | 350,000 | UNCH | $4,879 |
VERV | 350,000 | UNCH | $4,879 |
LANTHEUS HLDGS INC | 75,000 | +75,000 | $4,650 |
LNTH | 75,000 | +75,000 | $4,650 |
CENTESSA PHARMACEUTICALS PLC | 561,600 | UNCH | $4,470 |
CNTA | 561,600 | UNCH | $4,470 |
BIOHAVEN LTD | 81,963 | UNCH | $3,508 |
BHVN | 81,963 | UNCH | $3,508 |
GH RESEARCH PLC | 593,043 | UNCH | $3,440 |
GHRS | 593,043 | UNCH | $3,440 |
VYNE THERAPEUTICS INC | 1,394,336 | +1,394,336 | $3,249 |
VYNE | 1,394,336 | +1,394,336 | $3,249 |
BIOATLA INC | 1,181,115 | UNCH | $2,906 |
BCAB | 1,181,115 | UNCH | $2,906 |
NEUMORA THERAPEUTICS INC. | 92,293 | UNCH | $1,574 |
NMRA | 92,293 | UNCH | $1,574 |
See Full List: All Stocks Held By Cormorant Asset Management LP
— Including:
Biggest new positions
Biggest exits
Biggest increased positions
Biggest decreased positions
See Details: Top 10 Stocks Held By Cormorant Asset Management LP
Size ($ in 1000's)
At 12/31/2023: $2,089,116 At 09/30/2023: $1,714,348 Combined Holding Report Includes:
Cormorant Asset Management LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Cormorant Asset Management LP 13F filings. Link to 13F filings: SEC filings |